
USD $593.80
DOCEFREZ is a sterile injectable formulation containing Docetaxel, a powerful chemotherapeutic agent used in the treatment of various types of cancers. It is specifically designed for intravenous administration and is indicated for patients diagnosed with breast cancer, lung cancer, prostate cancer, and head and neck cancers.
DOCEFREZ INJECTION is a medication that contains Docetaxel as its active ingredient. It is primarily used in the treatment of various types of cancer, including breast cancer, lung cancer, prostate cancer, and stomach cancer. This injectable formulation is designed to inhibit cancer cell growth and division, making it an essential part of chemotherapy regimens.
The dosage of DOCEFREZ INJECTION is determined by a healthcare professional based on the patient's specific condition, body surface area, and overall health. It is typically administered intravenously every 3 weeks. Patients should follow their doctor's instructions carefully regarding dosage and scheduling.
Common side effects of DOCEFREZ INJECTION may include:
Patients should report any severe or persistent side effects to their healthcare provider immediately.
If you miss a dose of DOCEFREZ INJECTION, contact your healthcare provider to reschedule your appointment as soon as possible.
DOCEFREZ INJECTION is not recommended for use during pregnancy as it may harm the fetus. Women should inform their doctor if they are pregnant or planning to become pregnant.
Yes, DOCEFREZ INJECTION may interact with other medications. Always inform your healthcare provider about all medications and supplements you are taking.